Establishment of a Syngeneic Model of Hepatic Colorectal Oligometastases

Journal of Surgical Research

Volumn 136, Issue 2, 2006, Pages 288-293

  Mezhir, James J ^a   Smith, Kerrington D ^a   Kimchi, Eric T ^a   Park, James O ^a   Lopez, Carlos A ^a   Mauceri, Helena J ^a   Beckett, Micheal A ^a   Hellman, Samual ^a   Weichselbaum, Ralph R ^a   Posner, Mitchell C ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

animal model; BDIX rats; colorectal cancer; colorectal hepatic metastases; DHD K12 TRb (PROb) cells; hepatic metastases; metastasis; oligometastases; syngeneic model

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STAGING; CANCER SURGERY; COLORECTAL CANCER; CONTROLLED STUDY; HISTOLOGY; LAPAROTOMY; LIVER INJURY; LIVER METASTASIS; LIVER RESECTION; LIVER SURGERY; MALE; MOUSE; NONHUMAN; PERITONEAL DISEASE; PORTAL VEIN; PRIORITY JOURNAL; RAT; THORACOTOMY;

ANIMALS; BEHAVIOR, ANIMAL; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; LAPAROTOMY; LIVER NEOPLASMS; MALE; NEOPLASM TRANSPLANTATION; RATS; RATS, INBRED STRAINS; SPLEEN; THORACOTOMY;

EID: 33750931584     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2006.05.008     Document Type: Article

References (37)

1. Bentrem D.J., Dematteo R.P., and Blumgart L.H. Surgical therapy for metastatic disease to the liver. Annu Rev Med 56 (2005) 139
2. Choti M.A., Sitzmann J.V., Tiburi M.F., et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235 (2002) 759
3. Curley S.A., Izzo F., Abdalla E., and Vauthey J.N. Surgical treatment of colorectal cancer metastasis. Cancer Metastasis Rev 23 (2004) 165
4. Altendorf-Hofmann A., and Scheele J. A critical review of the major indicators of prognosis after resection of hepatic metastases from colorectal carcinoma. Surg Oncol Clin N Am 12 (2003) 165
5. Fong Y., Fortner J., Sun R.L., Brennan M.F., and Blumgart L.H. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg 230 (1999) 309
6. Hughes K.S., Simon R., Songhorabodi S., et al. Resection of the liver for colorectal carcinoma metastases: A multi-institutional study of indications for resection. Registry of Hepatic Metastases. Surg 103 (1988) 278
7. Kemeny M.M., Adak S., Gray B., et al. Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: Surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy-an intergroup study. J Clin Oncol 20 (2002) 1499
8. Kemeny N., Huang Y., Cohen A.M., et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 341 (1999) 2039
9. Curley S.A. Radiofrequency ablation of malignant liver tumors. Ann Surg Oncol 10 (2003) 338
10. Abdalla E.K., Vauthey J.N., Ellis L.M., et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239 (2004) 818
11. Kemeny N.E., Niedzwiecki D., Hollis D.R., et al. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: A randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol 24 (2006) 1395
12. Hurwitz H., Fehrenbacher L., Novotny W., et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350 (2004) 2335
13. Meyerhardt J.A., and Mayer R.J. Systemic therapy for colorectal cancer. N Engl J Med 352 (2005) 476
14. Adam R., Lucidi V., and Bismuth H. Hepatic colorectal metastases: Methods of improving resectability. Surg Clin North Am 84 (2004) 659
15. Ellis L.M., Curley S.A., and Grothey A. Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab. J Clin Oncol 23 (2005) 4853
16. Adam R., Avisar E., Ariche A., et al. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol 8 (2001) 347
17. Allen P.J., Kemeny N., Jarnagin W., DeMatteo R., Blumgart L., and Fong Y. Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. J Gastrointest Surg 7 (2003) 109
18. Leonard G.D., Brenner B., and Kemeny N.E. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol 23 (2005) 2038
19. Hellman S., and Weichselbaum R.R. Oligometastases. J Clin Oncol 13 (1995) 8
20. Kobaek-Larsen M., Thorup I., Diederichsen A., Fenger C., and Hoitinga M.R. Review of colorectal cancer and its metastases in rodent models: Comparative aspects with those in humans. Comp Med 50 (2000) 16
21. Khanna C., and Hunter K. Modeling metastasis in vivo. Carcinogenesis 26 (2005) 513
22. Shinozaki K., Ebert O., and Woo S.L. Treatment of multi-focal colorectal carcinoma metastatic to the liver of immune-competent and syngeneic rats by hepatic artery infusion of oncolytic vesicular stomatitis virus. Int J Cancer 114 (2005) 659
23. Alves A., Charre L., Panis Y., et al. Total vascular exclusion of the liver enhances the efficacy of retroviral-mediated associated thymidine kinase and interleukin-2 genes transfer against multiple hepatic tumors in rats. Surgery 133 (2003) 669
24. Martin M.S., Martin F., Michiels R., et al. An experimental model for cancer of the colon and rectum. Intestinal carcinoma induced in the rat 1,2-dimethylhydrazine. Digestion 8 (1973) 22
25. Dawson L.A., and Lawrence T.S. The role of radiotherapy in the treatment of liver metastases. Cancer J 10 (2004) 139
26. Adam R., Pascal G., Castaing D., et al. Tumor progression while on chemotherapy: A contraindication to liver resection for multiple colorectal metastases?. Ann Surg 240 (2004) 1052
27. Kobaek-Larsen M., Rud L., Oestergaard Soerensen F., and Ritskes-Hoitinga J. Laparoscopy of rats with experimental liver metastases: A method to assess new humane endpoints. Lab Anim 38 (2004) 162
28. Fukushima T., Nishihira J., Yoshiki T., et al. Evidence of dual function of macrophage migration inhibitory factor relevant to tumor progression and regression. Int J Mol Med 16 (2005) 119
29. Timmers M., Vekemans K., Vermijlen D., et al. Interactions between rat colon carcinoma cells and Kupffer cells during the onset of hepatic metastasis. Int J Cancer 112 (2004) 793
30. Ambiru S., Miyazaki M., Ito H., et al. Resection of hepatic and pulmonary metastases in patients with colorectal carcinoma. Cancer 82 (1998) 274
31. Labow D.M., Buell J.E., Yoshida A., Rosen S., and Posner M.C. Isolated pulmonary recurrence after resection of colorectal hepatic metastases: Is resection indicated?. Cancer J 8 (2002) 342
32. Mizuno N., Kato Y., Izumi Y., Irimura T., and Sugiyama Y. Importance of hepatic first-pass removal in metastasis of colon carcinoma cells. J Hepatol 28 (1998) 865
33. Mizuno N., Kato Y., Shirota K., et al. Mechanism of initial distribution of blood-borne colon carcinoma cells in the liver. J Hepatol 28 (1998) 878
34. Mezhir J.J., Advani S.J., Smith K.D., et al. Ionizing radiation activates late herpes simplex virus 1 promoters via the p38 pathway in tumors treated with oncolytic viruses. Cancer Res 65 (2005) 9479
35. Park J.O., Lopez C.A., Gupta V.K., et al. Transcriptional control of viral gene therapy by cisplatin. J Clin Invest 110 (2002) 403
36. Katz M.H., Takimoto S., Spivack D., Moossa A.R., Hoffman R.M., and Bouvet M. An imageable highly metastatic orthotopic red fluorescent protein model of pancreatic cancer. Clin Exp Metastasis 21 (2004) 7
37. Yang M., Jiang P., Yamamoto N., Li L., Geller J., Moossa A.R., and Hoffman R.M. Real-time whole-body imaging of an orthotopic metastatic prostate cancer model expressing red fluorescent protein. Prostate 62 (2005) 374